About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 414 record(s)
Req # A-2021-000711
Adverse Drug Reactions (ADRs) for Emend. Report numbers: 000721787, 000724592, 000724885, 000726049, E2B_02278629, E2B_02542491, 000722181, E2B_02326951, 000727291, 000727297, E2B_02571340.Organization: Health Canada
October 2021
Req # A-2021-000739
Adverse Drug Reaction (ADR) for HYDROCHLOROTHIAZIDE. Report number: E2B_03406806.Organization: Health Canada
October 2021
Req # A-2021-000742
Adverse Drug Reactions (ADRs). Report numbers: E2B_03995433, E2B_03996482, E2B_04002643, E2B_04007414, E2B_04009248, E2B_04015450, E2B_04017521, E2B_04030424, E2B_04047771, E2B_04087418, E2B_04087480, E2B_04087536, E2B_04087680, 000947513, 000951155, 000956312, 000956540, E2B_02132265, E2B_02132266, E2B_03061785.Organization: Health Canada
October 2021
Req # A-2021-000773
Adverse Drug Reactions (ADRs). Report numbers: 000948058, 000951093, 000954735, 000956312, 000956507, E2B_03998613, E2B_04002845, E2B_04077964.Organization: Health Canada
October 2021
Req # A-2021-000787
Adverse Drug Reaction (ADR) for Naltrexone. Report number: E2B_04051303. (ADR) for Hydromorphone. Report number: E2B_04095452. (ADR) for Cellcept. Report number: E2B_02227624.Organization: Health Canada
October 2021
Req # A-2021-000793
Adverse Drug Reactions (ADRs) for LEFLUNOMIDE. Report numbers: E2B_03379657, E2B_03456958, E2B_03508675.Organization: Health Canada
October 2021
Req # A-2021-000821
Adverse Drug Reaction (ADR) for LISINOPRIL. Report number: E2B_03482436.Organization: Health Canada
October 2021
Req # A-2021-000824
Adverse Drug Reaction (ADR) for METHOTREXATE. Report number: METHOTREXATE: E2B_03480589.Organization: Health Canada
October 2021
Req # A-2021-000829
Adverse Drug Reaction (ADR) for ZOPICLONE. Report number: E2B_03470440.Organization: Health Canada
October 2021
Req # A-2021-000839
Adverse Drug Reactions (ADRs) for LEFLUNOMIDE. Report numbers: E2B_03448962, E2B_03367560, E2B_03480462, 000928200, 000931884, 000925497, 000925516, 000925422, E2B_03458943, E2B_03338973.Organization: Health Canada
October 2021